JPH0625164A - Tb toxin - Google Patents

Tb toxin

Info

Publication number
JPH0625164A
JPH0625164A JP6077891A JP6077891A JPH0625164A JP H0625164 A JPH0625164 A JP H0625164A JP 6077891 A JP6077891 A JP 6077891A JP 6077891 A JP6077891 A JP 6077891A JP H0625164 A JPH0625164 A JP H0625164A
Authority
JP
Japan
Prior art keywords
toxin
soluble
solvent
hexane
methanol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP6077891A
Other languages
Japanese (ja)
Inventor
Kenji Ishii
賢二 石井
Tatsuya Ito
達也 伊藤
Yoshiaki Sugiura
義紹 杉浦
Yoshio Ueno
芳夫 上野
Kimiko Kobayashi
公子 小林
Giichi Horie
義一 堀江
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TOKYO RIKA UNIV
TOKYO RIKA, University of
Original Assignee
TOKYO RIKA UNIV
TOKYO RIKA, University of
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TOKYO RIKA UNIV, TOKYO RIKA, University of filed Critical TOKYO RIKA UNIV
Priority to JP6077891A priority Critical patent/JPH0625164A/en
Publication of JPH0625164A publication Critical patent/JPH0625164A/en
Pending legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

PURPOSE:To provide a novel compound useful as a proliferation inhibitor against myeloma cells, fibroblasts or the like and as a biochemical reagent. CONSTITUTION:TB toxin of the formula. This compound is obtained by culturing a fungus, Talaromyces bacillosporus-NMIC 10006 strain in a culture substrate of rice grains, extracting the mildewed rice grains therefrom with a high-polar solvent such as methanol, then transferring the solute into a non-polar solvent such as n-hexane, drying the solution under reduced pressure, subjecting the residue as the essence to column chromatography in a usual manner to remove impurities to give a crude TB toxin, followed by crystallization from a solvent. The properties of TB toxin are as follows. Appearance: pale yellow powder; molecular weight: 435; melting point: 137 to 138 deg.C; coloring reactions: positive to Liebermann-Burchard reaction (red), negative to the ninhydrin reaction; molecular formula: C28H37NO3; solubility: slightly soluble in water, soluble in ethanol, n-hexane, readily soluble in methanol, acetone, chloroform, and benzene.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は細胞毒性を有する新規化
合物に関する。さらに詳しくは、本発明は下記式
TECHNICAL FIELD The present invention relates to a novel compound having cytotoxicity. More specifically, the invention has the formula

【化2】 で表されるTBトキシンに関する。[Chemical 2] TB toxin represented by

【0002】[0002]

【従来の技術】真菌の細胞毒性代謝産物として、サイト
カラシン類やトリコテセン類化合物等が報告されてい
る。しかし、従来報告されている真菌代謝産物中に本発
明のTBトキシンと類似の構造を有するものは知られて
いない。
2. Description of the Related Art Cytochalasins, trichothecenes and the like have been reported as fungal cytotoxic metabolites. However, none of the previously reported fungal metabolites having a structure similar to the TB toxin of the present invention is known.

【0003】[0003]

【発明が解決しようとする課題】本発明の目的は、生体
における種々の反応や生体機能を明らかにするための生
化学試薬としてのみならず、医薬として有用な新規化合
物を提供することにある。
An object of the present invention is to provide a novel compound useful not only as a biochemical reagent for clarifying various reactions and biological functions in a living body but also as a medicine.

【0004】[0004]

【課題を解決するための手段】本発明者は、鋭意研究の
結果、米を基質として真菌タラロマイセス・バチロスポ
ラス(Talaromyces bacillosporus )NMIC10006株を
培養して得た人工かび米を有機溶媒で抽出し、この抽出
エキスより単離して得られた新規化合物に細胞毒性があ
ることを見出して本発明を完成し、これをTBトキシン
と命名した。
[Means for Solving the Problems] As a result of earnest research, the present inventor has extracted artificial fungus rice obtained by culturing the fungus Tlaromyces bacillosporus NMIC10006 strain using rice as a substrate with an organic solvent. The present invention was completed by discovering that the novel compound obtained by isolation from the extract has cytotoxicity, and named it TB toxin.

【0005】尚、本微生物タラロマイセス・バチロスポ
ラスNMIC10006株は千葉県立中央博物館に保管されてお
り、請求により誰にでも入手可能である。
[0005] The present microorganism, Talalomyces bacillus polas NMIC10006 strain, is stored in the Chiba Prefectural Central Museum and can be obtained by anyone upon request.

【0006】TBトキシンの製造法について説明する。
真菌タラロマイセス・バチロスポラス NMIC10006株を
米を基質として培養して得た人工かび米を極性の高い溶
媒で抽出した後、非極性溶媒に転溶させ、溶液を減圧乾
燥して抽出エキスを得、この抽出エキスを常法に従いカ
ラムクロマトグラフィーに付し不純物を分離して粗TB
トキシンを得、溶媒から結晶化してTBトキシンを製造
する。
A method for producing TB toxin will be described.
Artificial fungus rice obtained by culturing the fungus Talalomyces bacillus polas NMIC10006 strain using rice as a substrate is extracted with a highly polar solvent, then redissolved in a nonpolar solvent, and the solution is dried under reduced pressure to obtain an extract extract. The extract was subjected to column chromatography according to a conventional method to separate impurities to obtain crude TB.
Toxin is obtained and crystallized from solvent to produce TB toxin.

【0007】ここで、抽出用極性溶媒としてはメタノー
ル、アセトニトリルが適し、転溶用非極性溶媒としては
n−ヘキサンが適する。常法によるカラムクロマトグラ
フィーとしては、シリカゲルを充填したカラムを用い
て、クロロホルム−メタノール混液で溶出することによ
り粗TBトキシンを得ることができる。TBトキシンの
結晶化溶媒としてはエタノールが適する。上記のごとく
処理して得られるTBトキシンの物理的及び化学的性質
は次のとおりである。
Here, methanol and acetonitrile are suitable as the polar solvent for extraction, and n-hexane is suitable as the nonpolar solvent for transfer. As column chromatography by a conventional method, a crude TB toxin can be obtained by using a column packed with silica gel and eluting with a chloroform-methanol mixture. Ethanol is suitable as a solvent for crystallization of TB toxin. The physical and chemical properties of TB toxin obtained by the treatment as described above are as follows.

【0008】(a) 性 状:淡黄色粉末 (b) 分子量:435(マススペクトルのM+より) (c) 融 点:137〜138℃ (d) 赤外線吸収スペクトル(KBr)(cm-1(A) Properties: pale yellow powder (b) Molecular weight: 435 (from M + of mass spectrum) (c) Melting point: 137 to 138 ° C. (d) Infrared absorption spectrum (KBr) (cm -1 )

【図1】参照 νmax:2900、1610、1550、1410、1
120 (e) 核磁気共鳴スペクトル(CDCl3)(ppm) δ:0.88(1H)、1.04(3H)、1.08
(1H)、1.24(2H)、1.27(2H)、1.
33(1H)、1.51(3H)、1.53(1H)、
1.55(3H)、1.61(3H)、1.67(1
H)、1.72(2H)、1.81(1H)、2.08
(2H)、2.15(2H)、2.19(1H)、3.
27(1H)、3.76(1H)、3.97(1H)、
5.26(1H)、6.05(1H)、6.33(1
H)、7.10(1H)、7.48(1H) (f) 呈色反応 リーベルマン・バーチャード反応 陽性(赤
色) ニンヒドリン反応 陰性 (g) 分子式:C2837NO3 (h) 溶媒に対する溶解性 難溶:水、 可溶:エタノール、n−ヘキサン 易溶:メタノール、アセトン、クロロホルム、ベンゼン
1 reference νmax: 2900, 1610, 1550, 1410, 1
120 (e) Nuclear magnetic resonance spectrum (CDCl 3 ) (ppm) δ: 0.88 (1H), 1.04 (3H), 1.08
(1H), 1.24 (2H), 1.27 (2H), 1.
33 (1H), 1.51 (3H), 1.53 (1H),
1.55 (3H), 1.61 (3H), 1.67 (1
H), 1.72 (2H), 1.81 (1H), 2.08
(2H), 2.15 (2H), 2.19 (1H), 3.
27 (1H), 3.76 (1H), 3.97 (1H),
5.26 (1H), 6.05 (1H), 6.33 (1
H), 7.10 (1H), 7.48 (1H) (f) Color reaction Liebermann-Birchard reaction Positive (red) Ninhydrin reaction Negative (g) Molecular formula: C 28 H 37 NO 3 (h) Solvent Solubility: Poorly soluble: water, soluble: ethanol, n-hexane Easy soluble: methanol, acetone, chloroform, benzene

【0009】上記TBトキシンの細胞毒性は以下に示す
実験により確認した。10%の牛胎児血清、10mMの
HEPES緩衝液、6mMのL−グルタミンを含むRP
MI1640培地中、各種濃度のTBトキシンの存在下
ミエローマX63−Ag8−6.5.3細胞あるいは繊
維芽細胞Balb3T3細胞を2日間培養し、その増殖
をMTT法で測定した。これらの細胞の増殖の50%阻
害濃度はいずれも70ng/mlであった。
The cytotoxicity of the above TB toxin was confirmed by the following experiments. RP containing 10% fetal bovine serum, 10 mM HEPES buffer, 6 mM L-glutamine
Myeloma X63-Ag8-6.5.3 cells or fibroblast Balb3T3 cells were cultured for 2 days in MI1640 medium in the presence of various concentrations of TB toxin, and the proliferation was measured by the MTT method. The 50% inhibitory concentration of growth of these cells was 70 ng / ml in all cases.

【0010】[0010]

【実施例】次に実施例を挙げて本発明を詳細に説明す
る。 実施例1 10個のフラスコに白米を125gずつとり、オートク
レーブで滅菌し冷却後、滅菌水を40mlずつ加え、真
菌タラロマイセス・バチロスポラス NMIC10006株を接種
し、20日間25℃で培養して人工かび米を得る。この
人工かび米100g当り360mlのメタノール(計4
000ml)でブレンダー中で粉砕しながら抽出し、抽
出液を濾取し、減圧下溶媒を800mlまで濃縮し、n
−ヘキサン1200mlで抽出し、n−ヘキサン層を減
圧下留去し、抽出エキス2.78gを得た。
EXAMPLES The present invention will now be described in detail with reference to examples. Example 1 125 g each of white rice was placed in 10 flasks, sterilized in an autoclave and cooled, and then 40 ml of sterilized water was added, inoculated with the fungus Talalomyces batirosporus NMIC10006 strain, and cultured at 25 ° C. for 20 days to give artificial mold rice. obtain. 360 ml of methanol per 100 g of this artificial mold rice (total 4
(000 ml) while pulverizing in a blender, extracting the extract by filtration and concentrating the solvent under reduced pressure to 800 ml,
-Extract with 1200 ml of hexane and evaporate the n-hexane layer under reduced pressure to obtain 2.78 g of the extract.

【0011】この抽出エキスを小量のアセトンに溶解
し、5gのシリカゲル(ワコーゲル−200、和光純薬
製)に吸着させ、溶媒を蒸発除去した後、シリカゲル4
00gを充填したカラムの上に層積し、クロロホルムで
溶出した。TBトキシンを含む溶出液の溶媒を留去して
得た油状物質271.4mgをアセトンに溶解し、0.
1N蓚酸に1分間浸した後110℃12時間乾燥したシ
リカゲル(ワコーゲルC−200、和光純薬製)0.5
gに吸着させ、溶媒を蒸発除去した後、同じく蓚酸処理
したシリカゲル30gを充填したカラムの上に層積し、
クロロホルムで溶出し粗TBトキシン230mgを得
た。これをエタノールで結晶化し、TBトキシン115
mgを得た。その物理的及び化学的性質は下記の通りで
あった。
This extract was dissolved in a small amount of acetone, adsorbed on 5 g of silica gel (Wakogel-200, manufactured by Wako Pure Chemical Industries), and the solvent was removed by evaporation, followed by silica gel 4
It was layered on a column packed with 00 g and eluted with chloroform. 271.4 mg of an oily substance obtained by distilling off the solvent of the eluate containing TB toxin was dissolved in acetone, and
Silica gel (Wakogel C-200, manufactured by Wako Pure Chemical Industries, Ltd.) 0.5 which was soaked in 1N oxalic acid for 1 minute and then dried at 110 ° C. for 12 hours
g, and the solvent was removed by evaporation, and then layered on a column packed with 30 g of silica gel also treated with oxalic acid,
Elution with chloroform gave 230 mg of crude TB toxin. This was crystallized with ethanol and TB toxin 115
mg was obtained. Its physical and chemical properties were as follows:

【0012】(a) 性 状:淡黄色粉末 (b) 分子量:435(マススペクトルのM+より) (c) 融 点:137〜138℃ (d) 赤外線吸収スペクトル(KBr)(cm-1(A) Property: pale yellow powder (b) Molecular weight: 435 (from M + of mass spectrum) (c) Melting point: 137 to 138 ° C (d) Infrared absorption spectrum (KBr) (cm -1 )

【図1】参照 νmax:2900、1610、1550、1410、1
120 (e) 核磁気共鳴スペクトル(CDCl3)(ppm) δ:0.88(1H)、1.04(3H)、1.08
(1H)、1.24(2H)、1.27(2H)、1.
33(1H)、1.51(3H)、1.53(1H)、
1.55(3H)、1.61(3H)、1.67(1
H)、1.72(2H)、1.81(1H)、2.08
(2H)、2.15(2H)、2.19(1H)、3.
27(1H)、3.76(1H)、3.97(1H)、
5.26(1H)、6.05(1H)、6.33(1
H)、7.10(1H)、7.48(1H) (f) 呈色反応 リーベルマン・バーチャード反応 陽性(赤
色) ニンヒドリン反応 陰性 (g) 分子式:C2837NO3 (h) 溶媒に対する溶解性 難溶:水、 可溶:エタノール、n−ヘキサン 易溶:メタノール、アセトン、クロロホルム、ベンゼン
1 reference νmax: 2900, 1610, 1550, 1410, 1
120 (e) Nuclear magnetic resonance spectrum (CDCl 3 ) (ppm) δ: 0.88 (1H), 1.04 (3H), 1.08
(1H), 1.24 (2H), 1.27 (2H), 1.
33 (1H), 1.51 (3H), 1.53 (1H),
1.55 (3H), 1.61 (3H), 1.67 (1
H), 1.72 (2H), 1.81 (1H), 2.08
(2H), 2.15 (2H), 2.19 (1H), 3.
27 (1H), 3.76 (1H), 3.97 (1H),
5.26 (1H), 6.05 (1H), 6.33 (1
H), 7.10 (1H), 7.48 (1H) (f) Color reaction Liebermann-Birchard reaction Positive (red) Ninhydrin reaction Negative (g) Molecular formula: C 28 H 37 NO 3 (h) Solvent Solubility: Poorly soluble: water, soluble: ethanol, n-hexane Easy soluble: methanol, acetone, chloroform, benzene

【図面の簡単な説明】[Brief description of drawings]

【図1】本発明のTBトキシンの赤外線吸収スペクトル
(KBr)を示す図面である。
FIG. 1 is a drawing showing an infrared absorption spectrum (KBr) of TB toxin of the present invention.

───────────────────────────────────────────────────── フロントページの続き (72)発明者 上野 芳夫 東京都新宿区市ヶ谷船河原町12 東京理科 大学薬学部内 (72)発明者 小林 公子 埼玉県和光市広沢2−1 理化学研究所内 (72)発明者 堀江 義一 千葉県千葉市青葉955−2 千葉県中央博 物館内 ─────────────────────────────────────────────────── ─── Continuation of the front page (72) Inventor Yoshio Ueno 12 Ichigaya, Funagawara-cho, Shinjuku-ku, Tokyo Inside the Faculty of Pharmaceutical Sciences, Tokyo University of Science (72) Kimiko Kobayashi 2-1 Hirosawa, Wako City, Saitama Prefecture (72) Inventor Horie Yoshikazu Chiba Chiba City Aoba 955-2 Chiba Prefecture Central Museum Building

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】この発明は下記式 【化1】 で表される化合物(TBトキシン)。1. The present invention comprises the following formula: A compound represented by (TB toxin).
JP6077891A 1991-02-22 1991-02-22 Tb toxin Pending JPH0625164A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP6077891A JPH0625164A (en) 1991-02-22 1991-02-22 Tb toxin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6077891A JPH0625164A (en) 1991-02-22 1991-02-22 Tb toxin

Publications (1)

Publication Number Publication Date
JPH0625164A true JPH0625164A (en) 1994-02-01

Family

ID=13152090

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6077891A Pending JPH0625164A (en) 1991-02-22 1991-02-22 Tb toxin

Country Status (1)

Country Link
JP (1) JPH0625164A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102532026A (en) * 2011-11-16 2012-07-04 云南大学 Talamidolide compounds and application thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102532026A (en) * 2011-11-16 2012-07-04 云南大学 Talamidolide compounds and application thereof

Similar Documents

Publication Publication Date Title
Buechi et al. Four new mycotoxins of Aspergillus clavatus related to tryptoquivaline
JPH05502163A (en) new product
CN115595343A (en) Active secondary metabolite in cherry tomato rhizosphere soil microorganism and preparation and application thereof
CN109020943B (en) Antituberculous polyketone compound and preparation method and application thereof
CN110218200B (en) Cyclic depsipeptide compound in mangrove endophytic fungi and preparation method and application thereof
CN109942658B (en) Heteroterpene compounds, preparation method and application thereof, and antitumor drugs
WO2001064931A1 (en) Manufacture and purification of mycophenolic acid
JPH0341475B2 (en)
JPH0625164A (en) Tb toxin
US4975368A (en) Novel androst-4-ene-3,17-dione derivatives and method for preparing same
CA1109406A (en) Production of monorden
CN105802872B (en) Pseudomonas fluorescens, method for producing phenazine amide and application thereof
CN110872338B (en) Indole diterpenoid compound and preparation method and application thereof
JP2873894B2 (en) Cyclic depsipeptide and method for producing the same
JP2695225B2 (en) New substance UCT-1003
US3701787A (en) Preparation of 5,6-dihydro-5-hydroxy-6-propenyl-2-pyrone by fermentation and derivatives thereof
JPH11269125A (en) Cyathane derivative and nerve growth factor production inducer containing the same as active ingredient
US5254727A (en) Acyclic tricarboxylic acid compounds
JPH0769961A (en) Cyathane derivative, and neuro growth factor production inducing agent and antimicrobial agent using the same as active component
FR2557455A1 (en) ANTIBIOTIC NEW 81-484 ANTITUMER AND ITS PRODUCTION
KR20020037730A (en) New iodolocarbazole alkaloids from a marine actinomycete
CN108822119B (en) Erythronolide ketone compound with autophagy activation activity, preparation method and pharmaceutical application thereof
US3803307A (en) Antibiotic sl 21429
JP2734136B2 (en) Octadecenoic acid derivative and cell killer for cervical cancer cells containing the same as active ingredient
JPH0770168A (en) Cyathane derivative and nerve growth factor production inducer containing the same and antimicrobial agent